back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-25 23:22 Tx date 2023-01-24 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,725
+765,000 vol $0.065 each |
1,076,120 | |
| Filed 2020-12-23 23:14 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,668
+36,120 vol $0.24 each |
107,154 | |
| Filed 2020-12-23 23:13 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,668.80
-36,120 vol $0.24 each |
311,120 | |
| Filed 2020-12-22 21:57 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-2,430,680 vol |
347,240 | |
| Filed 2020-12-22 21:55 Tx date 2020-12-22 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-497,241 vol |
71,034 | |
| Filed 2020-08-10 21:45 Tx date 2020-08-10 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$27,500
+500,000 vol $0.055 each |
2,777,920 | |
| Filed 2019-08-31 12:14 Tx date 2019-08-23 |
$SZLS
StageZero Life Sciences Ltd. |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,896
+938,960 vol $0.10 each |
2,277,920 | |
| Filed 2018-07-03 Tx date 2018-05-28 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-20,416.34
-20,833 vol $0.98 each |
1,138,960 | |
| Filed 2018-07-03 Tx date 2018-06-28 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$160,000
+200,000 vol $0.80 each |
1,338,960 | |
| Filed 2018-04-04 Tx date 2018-04-02 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,000
+200,000 vol $0.11 each |
1,159,793 | |
| Filed 2017-07-14 Tx date 2017-07-14 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$130,703
+568,275 vol $0.23 each |
568,275 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,000
+100,000 vol $0.19 each |
959,793 | |
| Filed 2017-06-12 Tx date 2017-04-26 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-12,000
-12,500 vol $0.96 each |
859,793 | |
| Filed 2016-08-27 Tx date 2016-08-22 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,000
-200,000 vol $0.145 each |
0 | |
| Filed 2016-08-12 Tx date 2016-05-16 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-14,250
-12,500 vol $1.14 each |
797,293 | |
| Filed 2016-07-05 Tx date 2016-06-30 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,750
+75,000 vol $0.17 each |
884,793 | |
| Filed 2015-12-23 Tx date 2015-12-22 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,668
+288,960 vol $0.03 each |
809,793 | |
| Filed 2015-08-20 Tx date 2015-07-08 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-29,001.60
-12,720 vol $2.28 each |
520,833 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$GEN
GeneNews Limited |
Glorikian, Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+75,000 vol $0.32 each |
533,553 |